Jeff E. Knight

Chief Operating Officer

Jeff E. Knight (Chief Operating Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Crinetics Pharmaceuticals, Inc. (CRNX). The largest single filing was $3.4M of CRNX (85,163 sh × $40.10, as filed), executed Apr 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.8M

shares × price, as filed

Last traded

Apr 8

Filed Apr 10

Median ADV $326.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

CRNX

Crinetics Pharmaceuticals, Inc. CRNX · 0 buys · 3 sells 3 filings

Recent filings

CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $3.4M
85,163 sh × $40.10
Exec Apr 8
Filed Apr 10 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $370K
9,911 sh across 2 lots
Exec Mar 16
Filed Mar 18 · 5:30 PM ET CRNXSALE Crinetics Pharmaceuticals, Inc. View filing → $232K
6,801 sh × $34.17
Exec Mar 19 2025
Filed Mar 21 2025 · 5:30 PM ET